Company
Halia Therapeutics, Inc.
Halia Therapeutics, Inc. has 2 drugs tracked on RxWires: 2 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Ofirnoflast | Phase 2 | Myelodysplastic Syndromes |
| HT-6184 | Phase 2 | Myelodysplastic Syndrome |
Latest
No recent events.
Follow Halia Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.